Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

March 6, 2018

Primary Completion Date

April 28, 2018

Study Completion Date

June 7, 2018

Conditions
Intermittent Claudication
Interventions
DRUG

Cilostazol 100 mg

One immediately-release tablet (Cilostazol 100 mg) at 08:00 and another at 20:00, twice daily oral dose (total daily dose of 200 mg)

DRUG

PMR 150 mg

Two extended-release tablets (PMR 150 mg) at 08:00, single oral dose (total daily dose of 300 mg)

DRUG

PMR 200 mg

Two extended-release tablets (PMR 200 mg/tablet) at 08:00, single oral dose (total daily dose of 400 mg)

Trial Locations (1)

65802

Bio-Kinetic Clinical Applications, LLC, Springfield

All Listed Sponsors
lead

Genovate Biotechnology Co., Ltd.,

INDUSTRY